deltatrials
Completed PHASE3 NCT00000481

Women's Health Trial: Feasibility Study in Minority Populations

Sponsor: National Cancer Institute (NCI)

Updated 6 times since 2017 Last updated: Feb 13, 2017 Started: Sep 30, 1991 Completion: Jan 31, 1996

A PHASE3 clinical study on Cardiovascular Diseases and Coronary Disease, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 6 data snapshots since 1991. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

Show 1 earlier version
  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Sep 1991

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.